Literature DB >> 25390526

Extensive choroidal infiltrates in choroidal biopsy proven ocular sarcoidosis.

Ling Chen1, Gezhi Xu.   

Abstract

PURPOSE: To report a rare manifestation of ocular sarcoidosis.
METHODS: Case report.
RESULTS: A 50-year-old man was misdiagnosed and treated as acute retinal necrosis and was referred to our clinic. Fundus examination revealed bilateral, extensive, confluent, subretinal yellowish white infiltrates throughout the fundus. Choroidal biopsy was performed and revealed noncaseating granuloma.
CONCLUSION: This case presents a rare manifestation of ocular sarcoidosis as extensive confluent choroidal infiltrates throughout the fundus. The lack of the evidence for systemic sarcoidosis and unusual ocular presentation necessitate choroidal biopsy to confirm the diagnosis.

Entities:  

Year:  2013        PMID: 25390526     DOI: 10.1097/ICB.0b013e3182670ec3

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  4 in total

Review 1.  Advances and potential new developments in imaging techniques for posterior uveitis. Part 1: noninvasive imaging methods.

Authors:  Ilknur Tugal-Tutkun; Carl P Herbort; Alessandro Mantovani; Piergiorgio Neri; Moncef Khairallah
Journal:  Eye (Lond)       Date:  2020-07-16       Impact factor: 3.775

Review 2.  Optical coherence tomography angiography in uveitis.

Authors:  Paris Tranos; Evdoxia-Maria Karasavvidou; Olga Gkorou; Carlos Pavesio
Journal:  J Ophthalmic Inflamm Infect       Date:  2019-12-23

Review 3.  Choroidal sarcoid granuloma: a case report and review of the literature.

Authors:  Dany G Hage; Charbel H Wahab; Wajiha J Kheir
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-09-29

Review 4.  Pearls and pitfalls of optical coherence tomography angiography in the multimodal evaluation of uveitis.

Authors:  Francesco Pichi; David Sarraf; Mariachiara Morara; Shahana Mazumdar; Piergiorgio Neri; Vishali Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2017-10-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.